Scholars@Duke

Randomized Phase 2 (Ph2) clinical trial of Lerapolturev (previously known as PVSRIPO) in recurrent glioblastoma (rGBM)

Clinical Trial Grant
Duke Scholars
James Emmett Herndon II
Co Investigator James Emmett Herndon II Biostatistics & Bioinformatics, Division of Biostatistics
Matthias Gromeier
Principal Investigator Matthias Gromeier Neurosurgery, Neuro-Oncology
Annick Desjardins
Co-Principal Investigator Annick Desjardins Neurosurgery, Neuro-Oncology
Madison Shoaf
Co Investigator Madison Shoaf Neurosurgery, Neuro-Oncology

Administered By

Neurosurgery, Neuro-Oncology

Awarded By

Brain Tumor Research Charity

Start Date

May 1, 2024

End Date

April 30, 2027
 

Administered By

Neurosurgery, Neuro-Oncology

Awarded By

Brain Tumor Research Charity

Start Date

May 1, 2024

End Date

April 30, 2027